- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 782
Cala Health holds on to $50m
Alphabet, Novartis and Johnson & Johnson have contributed to a series C round for Cala Health, which is preparing to release its wearable hand-tremor treatment device.
May 22, 2019Sun Basket orders $30m in fresh funding
Unilever Ventures participated in a series E round that increased the healthy meal delivery service's overall funding to $125m.
May 22, 2019Holodeck VR stations ProSiebenSat.1
Free-roam VR experience technology company Holodeck VR has been backed by ProSiebenSat.1 Media, raising the prospect of business development collaborations with the corporate's television networks.
May 22, 2019Upswing sizes up $2m
Stanford-backed student support platform UpSwing has added $2m from investors including Impact America Fund to take its total to approximately $5m.
May 22, 2019Robin lands on $20m for series B
Allegion's corporate venturing arm has taken part in a $20m round for the office management software provider, whose early backers include Autodesk and Konica Minolta.
May 22, 2019SIG helps Shanzhen take care of funding
Susquehanna International Group has led a series B round for elderly healthcare services provider Shanzhen that was in the eight-figure dollar range.
May 22, 2019Unit DX marks $25.5m in portfolio funding
Members of science incubator Unit DX have obtained $25.5m of capital altogether since launch in 2017, with many of its residents hailing from University of Bristol.
May 21, 2019Schrödinger boxes up $110m
The drug development software provider has added $25m to an Alphabet and Wuxi AppTech-backed first tranche it closed in January.
May 21, 2019Auth0 logs into $103m series E
Telstra and NTT Docomo-backed dentity management platform developer Auth0 is now valued at more than $1bn after closing its latest round.
May 21, 2019Reneo generates $50m in series A round
Lundbeckfond Ventures contributed to a round that will fund clinical trials for Reneo Pharmaceuticals' mitochondrial disease therapies.
May 21, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


